Dexcom, a global leader in real-time continuous glucose monitoring, is inviting members of the diabetes community to express their unique journey with diabetes by creating
DC4U, an immunology company developing innovative treatments for auto-immune diseases and allergies, has been awarded a €1.7m Eurostars (SiaDM) grant, together with a Leiden University
An international drive to highlight the importance of the prevention and adequate management of diabetes has been proposed by a team of the world’s leading
A leading charity partnership is urging more people to check their risk of Type 2 diabetes through a free online tool as new figures reveal
Researchers at the Massachusetts Institute of Technology (MIT) have developed a new drug capsule with a robotic cap for improved drug delivery. Because large-protein drugs
Use of an older class of Type 2 diabetes drugs called glitazones (also known as thiazolidinediones or TZDs) is linked to a 22% reduced risk
The National Institute for Health and Care Research (NIHR) has announced a £26 million investment in an NIHR Leicester Biomedical Research Centre (BRC) – a
Eli Lilly plans to introduce a personalized diabetes management platform that integrates with technologies, including Dexcom’s continuous glucose monitoring (CGM) systems. The platform, branded Tempo,
A team of University of British Columbia (UBC) researchers has discovered that insulin from the oral insulin tablets they are developing is absorbed by rats
